McLaughlin Gerald W. 4/A
4/A · Neos Therapeutics, Inc. · Filed Mar 22, 2019
Insider Transaction Report
Form 4/AAmended
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-03-01+392,688→ 392,688 totalExercise: $2.31Exp: 2029-03-01→ Common Stock (392,688 underlying)
Footnotes (1)
- [F1]This stock option will vest in four equal, annual installments beginning on March 1, 2019.